Flow cytometry is a powerful analytical tool employed in several industries. This article will provide an overview of its use in the field of botany. Flow cytometry measures the chemical and physical ...

Flow cytometry is a robust analytical tool used to count cells in a solution. It provides a multi-parametric analysis of single cells (or particles) as they move past a laser, producing both scattered ...

Recent advances in imaging techniques have revolutionised flow cytometry and microscopy by integrating high-throughput cell analysis with high‐resolution imaging. These technologies now harness novel ...

With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...

Spectral flow cytometry is an established technology that offers the ability to extract autofluorescence, gives researchers more flexibility when it comes to fluorochrome selection, and facilitates ...

A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...

Sonal Manohar is an Assistant Professor at the Sunandan Divatia School of Science (Mumbai, India) specializing in cancer biology and cell signaling. She has recently co-authored two papers published ...

Flow-based methods allow researchers to collect multiparameter data from individual cells in their samples, but the fate of samples depends on the instrument. In addition to cell analysis, cell ...

An eclectic range of applications will be discussed covering numerous areas of biology, including new developments in instrumentation. This event has CPD accreditation and will have a troubleshooting ...

Acute myeloid leukemia (AML) is a cancer type that originates in the bone marrow. Despite being considered a rare disease, it is the most common type of acute leukemia and progresses rapidly, ...

The global flow cytometry market is projected to grow at a CAGR of nearly 9% over the next several years, driven by rising cases of cancer, HIV/AIDS, hematological disorders, and other chronic ...